Afexa Life Sciences Inc. trades
on the Toronto Stock Exchange
under the symbol FXA

Contact Investors Relations

Ms. Jane Tulloch
Senior Director, Investors Relations
Afexa Life Sciences Inc.
1-780 577-3724

IR@afexa.com


Board of Directors


Jack Moffatt, MBA, ICD.D – Chairman and Chief Executive Officer
Mr. Moffatt has an extensive background in packaged goods retailing and manufacturing in both Canada and the United States, and has held senior management positions in several other industries over the course of his career. For several years he has led an advisory company specializing in corporate revitalization and strategic planning. Mr. Moffatt is a former Chair and CEO of The Great Atlantic & Pacific Company of Canada (A&P Canada), and a former President of First National Supermarkets in New England. He holds an MBA degree from the University of Toronto. Mr. Moffatt was appointed to the Board of Directors of Afexa in September 2008 as Executive Chairman and assumed corporate oversight responsibilities in October 2008. In December 2009, he became Chairman and Chief Executive Officer of the Corporation.
   
J. Douglas Gilpin, C.A. – Lead Director
Mr. Gilpin is a Chartered Accountant with more than 30 years of business advisory and consultancy experience. He was a partner with KPMG LLP from 1981 until his retirement from the firm in 1999. His practice focused on business advisory and assurance matters and involved work with numerous companies in the biotechnology field. Mr. Gilpin is a Director of Canada Health Infoway Inc. / Inforoute Sante du Canada, and Chair of its Governance Committee and a member of its Finance, Investment & Audit Committee. He is also a public member of the Finance Investment & Audit Committee for the College of Physicians & Surgeons of Alberta. Mr. Gilpin served on the Board of Directors of ViRexx Medical Corp. as Chair of both the Audit Committee and the Governance and Nominating Committee. Mr Gilpin was appointed as a member of the new Alberta Innovates – Technology Futures Committee, a Provincial research and innovation initiative established to ensure Alberta is competitive in the global economy. He is a Director and Chairman of the Audit Committee for the Institute of Health Economics of Alberta. Mr. Gilpin is the Chair of Afexa’s Audit Committee and a member of the Human Resources and Compensation Committee of the Corporation. Mr. Gilpin was appointed Lead Director of the Corporation in June 2009.
   
Maurice (Ted) Bilyea, M.A., B.A.
After a 35-year career with Maple Leaf Foods Inc., a consumer packaged food company headquartered in Toronto with operations across Canada, and in the United States, United Kingdom, Asia and Mexico. Mr. Bilyea retired in 2005 as Executive Vice-President of Maple Leaf Foods Inc. Prior to that, he was President of Maple Leaf Foods International. Mr. Bilyea joined Canada Packers Limited, Maple Leaf Foods’ predecessor company, in 1971, starting in the domestic meat operations division before moving to international trade as a specialist in Asian business development. Today, Mr. Bilyea is an agri-food consultant specializing in innovation for clients in the private and public sectors. He is Chair of the Science Advisory Board of Agriculture and Agri-food Canada. He also chairs the Board of the Metals in the Human Environment Research Network (MITHE-RN), serves on the Board of the Prion Research Network (PrioNet) and the Advisory Board of the Canadian Agri-food Policy Institute. As well, Mr. Bilyea sits on the Board of Paterson Global Foods Inc. and the Alberta Livestock and Meat Agency. He is active with the Food Processors of Canada, an association he chaired for several years. Mr. Bilyea is a member of the Human Resources and Compensation Committee of the Corporation.
   
Robert B. Church, PhD, B.Sc., M.Sc.
Robert B. Church is Professor Emeritus of the Faculty of Medicine of the University of Calgary. He is a past President of the Calgary Exhibition and Stampede and has served on the Board of Directors of several companies, including Connaught Laboratories Ltd., Vencap Equities Alberta Ltd., Biostar Inc. and Ciba-Geigy Ltd. He is currently on the Board of AVAC Ltd. and Canadian Agri-Food Policy Institute and is the founding Chairman of the Board of the Alberta Science and Research Authority and is currently Chair Emeritus. Dr. Church was a founding member of the Natural Sciences and Engineering Research Council of Canada and of the Canadian Institute for Advanced Research and has been a member of the Board of the Medical Research Council of Canada and of the Alberta Research Council. He has been a founder and/or advisor of a number of start-up high technology companies, including Alberta Livestock Transplants Ltd. (1971) through to GangaGen Inc. (2004), as well as a member of the Investment Committees of the Boards of Vencap Equities Ltd. and AVAC Ltd. Through his numerous activities, Dr. Church has over forty years experience representing investments in high technology start-up companies. In 2000, Dr. Church was appointed to the Order of Canada, this country’s highest honour, for lifetime achievement. Dr Church is a member of the Corporate Governance and Nominating Committee of the Corporation.
   
John A. Rogers, FCA
Mr. Rogers has had a distinguished career, including 32 years in senior management positions with MDS Inc. and MDS Capital Corp. He retired from his position as President of MDS Inc. in June of 2005. From 1973 Mr. Rogers held a number of senior management roles within MDS Inc., enjoying a steady progression through the ranks. Mr. Rogers is a recipient of the Rotman Distinguished Business Alumni Award from the University of Toronto’s Rotman School of Management – the highest honour bestowed upon graduates of the School. He attended the Advanced Management Program at Harvard University, is a Fellow of the Institute of Chartered Accountants and received a B.A. in Commerce from the University of Toronto. He serves as a member of the Board of Directors of several public and private organizations. He serves on the Audit Committee of the Corporation and is Chair of the Corporate Governance and Nominating Committee of Afexa.
   
David T. Weyant, QC, BA, LL.B, ICD.D
David Weyant is the Senior Vice President and General Counsel for Alberta Health Services, the largest fullyintegrated, publicly-funded health care system in Canada and one of Canada’s five largest employers. He has been practicing law for almost 20 years, both as a litigator and as a corporate/commercial lawyer. In the latter capacity he negotiated transactions including securities, outsourcing, private/public partnerships, lending, financing and other corporate commercial transactions. His clients included corporations in the pharmaceutical, agri/food, healthcare and biotech sectors. He is frequently invited to provide his expertise on various aspects of risk management, corporate/commercial law, health law, and corporate governance. He has served on various boards and served as a member of the executive of the Association of General Counsel of Alberta, as well as local and national bar association sections. He was selected by Alberta’s Minister of Finance to sit on the provincial financial committee advising the Government on the management, governance, and investment policies of its $40 billion Heritage Trust Fund. Mr. Weyant is a registered trade-mark agent. He is a member of the Canadian College of Health Service Executives and a Board member of the Liability and Property Insurance Plan Advisory Board for the Public Health Authorities of Alberta. Mr. Weyant has successfully completed the Directors Education Program and has earned his ICD.D professional director certification from the Institute of Corporate Directors. He is Chair of the Human Resources and Compensation Committee of the Corporation.
   
William B. White, B.Sc.
William White is the retired President of DuPont Canada Company (“DuPont Canada”). He held a variety of global business unit leadership roles in his 34 years with E.I. du Pont de Nemours and Company (“DuPont”). Prior to his 2006 appointment as President of DuPont Canada, Mr. White worked across DuPont leading programs focused on growth through marketing and sales transformation, developing emerging markets, and step change business strategies. He was Director of Business Improvement at DuPont’s headquarters in Wilmington, Delaware, before being promoted to President of DuPont Canada. He is currently a partner in CBW Associates, a Canadian business consulting firm. A graduate of Purdue University in West Lafayette, Indiana (B.Sc., Mechanical Engineering), he is a 2009 Distinguished Engineering Alumnus and chairs Purdue’s Mechanical Engineering advisory committee. Mr. White also serves on the Board of Directors of a number of non-profit boards. Mr. White joined the Board of Directors of Afexa in November 2009 and serves on the Audit Committee, Corporate Governance and Nominating Committee and is a member of the International Intellectual Property and Regulatory Development Sub-Committee of the Corporation.